Interleukin 12: a new clinical player in cytokine therapy
Open Access
- 1 April 1995
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 71 (4), 655-659
- https://doi.org/10.1038/bjc.1995.130
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- The interleukin‐12 subunit p40 specifically inhibits effects of the interleukin‐12 heterodimerEuropean Journal of Immunology, 1993
- Gene expression and secretion of cytokines and cytokine receptors from highly purified CD56+ natural killer cells stimulated with interleukin‐2, interleukin‐7 and interleukin‐12European Journal of Immunology, 1993
- Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin‐12) on cell‐mediated cytotoxicity against tumor‐derived and virus‐infected cellsEuropean Journal of Immunology, 1993
- Interleukin-12 and its role in the generation of TH1 cellsImmunology Today, 1993
- Assignment of genes encoding a unique cytokine (IL12) composed of two unrelated subunits to chromosomes 3 and 5Genomics, 1992
- Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF.The Journal of Experimental Medicine, 1992
- Induction of TH1 and TH2 responses: a key role for the ‘natural’ immune response?Immunology Today, 1992
- Sequence similarity between NKSF and the IL-6/G-CSF familyImmunology Today, 1992
- Homology of the p40 subunit of natural killer cell stimulatory factor (NKSF) with the extracellular domain of the interleukin-6 receptorCell, 1991
- Characterization of a factor(s) which synergizes with recombinant interleukin 2 in promoting allogeneic human cytolytic T-lymphocyte responses in vitroCellular Immunology, 1988